Spots Global Cancer Trial Database for A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Official Title: A Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
Study ID: NCT02147197
Study Description
Brief Summary: This study will evaluate the superiority of ulipristal acetate versus placebo for the treatment of abnormal uterine bleeding associated with uterine fibroids
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Watson Investigational Site 125, Tucson, Arizona, United States
Watson Investigational Site 102, San Diego, California, United States
Watson Investigational Site 112, Denver, Colorado, United States
Watson Investigational Site 115, Lakewood, Colorado, United States
Watson Investigational Site 116, Milford, Connecticut, United States
Watson Investigational Site 114, Washington, District of Columbia, United States
Watson Investigational Site 106, Clearwater, Florida, United States
Watson Investigational Site 122, Lake Worth, Florida, United States
Watson Investigational Site 130, Miami, Florida, United States
Watson Investigational Site 105, New Port Richey, Florida, United States
Watson Investigational Site 104, Orlando, Florida, United States
Watson Investigational Site 120, Orlando, Florida, United States
Watson Investigational Site 103, Atlanta, Georgia, United States
Watson Investigational Site 123, Atlanta, Georgia, United States
Watson Investigational Site 111, Augusta, Georgia, United States
Watson Investigational Site 124, Idaho Falls, Idaho, United States
Watson Investigational Site 131, Brownsburg, Indiana, United States
Watson Investigational Site 129, Shawnee Mission, Kansas, United States
Watson Investigational Site 132, Metairie, Louisiana, United States
Watson Investigational Site 110, Norfolk, Nebraska, United States
Watson Investigational Site 113, Albuquerque, New Mexico, United States
Watson Investigational Site 121, Raleigh, North Carolina, United States
Watson Investigational Site 109, Winston-Salem, North Carolina, United States
Watson Investigational Site 107, Columbus, Ohio, United States
Watson Investigational Site 119, Jenkintown, Pennsylvania, United States
Watson Investigational Site 108, Myrtle Beach, South Carolina, United States
Watson Investigational Site 101, Chattanooga, Tennessee, United States
Watson Investigational Site 126, Memphis, Tennessee, United States
Contact Details
Name: Anna Chan
Affiliation: Allergan
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
